What is Evommune 's derivative liabilities?

Evommune (EVMN) reported derivative liabilities of $135.65K in Q1 2026.

What does derivative liabilities mean?

Fair value of derivative contracts in a net loss position — amounts the firm owes to counterparties on hedging and trading derivatives.

Evommune EVMN Derivative liabilities

Derivative liabilities at other companies

Virtu FinancialVIRT

$456.52M+51.2%

JBT Marel CorporationJBTM

$0—

Chord EnergyCHRD

$112.16M+125%

Axos FinancialAX

$0—

CVR EnergyCVI

$178M—

Portland General ElectricPOR

$236M+46.6%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's derivative liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's derivative liabilities?: Evommune (EVMN) reported derivative liabilities of $135.65K in Q1 2026.
What does derivative liabilities mean?: Fair value of derivative contracts in a net loss position — amounts the firm owes to counterparties on hedging and trading derivatives.